| John David Hayes, MD | |
|
210 Brooks St, Suite 200, Charleston, WV 25301-1855 | |
| (304) 388-1930 | |
| (304) 388-1929 |
| Full Name | John David Hayes |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 21 Years |
| Location | 210 Brooks St, Charleston, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336328467 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0122X | Surgery - Plastic And Reconstructive Surgery | 24574 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Charleston Area Medical Center | Charleston, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Charleston Area Medical Center Inc | 3375441637 | 675 |
News Archive
If hospital doctors around the world often struggle to become those health centaurs, half professionals and half managers, that modern healthcare organizations need, the main responsibility is not their resistance to change, but the lack of effective support from the organization, according to a study by Marco Sartirana (CERGAS, Bocconi University), Graeme Currie (Warwick Business School), and Mirko Noordegraaf (Utrecht School of Governance), published by the Public Management Review.
Veracyte, Inc., a molecular diagnostics company pioneering the field of molecular cytology, today announced that two Blue Cross Blue Shield–affiliated organizations, Highmark Inc. and Horizon Blue Cross Blue Shield of New Jersey, have issued positive coverage policies for the company's Afirma Gene Expression Classifier (GEC).
Calbiotech, Inc. announced today that it has been awarded a Small Business Innovative Research (SBIR) Phase I contract by the U.S. Army Medical Research and Material command. Under terms of the agreement, Calbiotech will develop analyte specific reagents (ASRs) for the diagnosis of Dengue virus.
Advanced metastatic melanoma is a disease that has proven difficult to eradicate. Despite the success of melanoma-targeting drugs, tumors inevitably become drug resistant and return, more aggressive than before. In the current issue of the journal Cancer Cell, however, researchers at The Wistar Institute describe how they increase the effectiveness of anti-melanoma drugs by combining anticancer therapies with diabetes drugs.
› Verified 8 days ago
| Entity Name | Charleston Area Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124248752 PECOS PAC ID: 3375441637 Enrollment ID: O20031223000426 |
News Archive
If hospital doctors around the world often struggle to become those health centaurs, half professionals and half managers, that modern healthcare organizations need, the main responsibility is not their resistance to change, but the lack of effective support from the organization, according to a study by Marco Sartirana (CERGAS, Bocconi University), Graeme Currie (Warwick Business School), and Mirko Noordegraaf (Utrecht School of Governance), published by the Public Management Review.
Veracyte, Inc., a molecular diagnostics company pioneering the field of molecular cytology, today announced that two Blue Cross Blue Shield–affiliated organizations, Highmark Inc. and Horizon Blue Cross Blue Shield of New Jersey, have issued positive coverage policies for the company's Afirma Gene Expression Classifier (GEC).
Calbiotech, Inc. announced today that it has been awarded a Small Business Innovative Research (SBIR) Phase I contract by the U.S. Army Medical Research and Material command. Under terms of the agreement, Calbiotech will develop analyte specific reagents (ASRs) for the diagnosis of Dengue virus.
Advanced metastatic melanoma is a disease that has proven difficult to eradicate. Despite the success of melanoma-targeting drugs, tumors inevitably become drug resistant and return, more aggressive than before. In the current issue of the journal Cancer Cell, however, researchers at The Wistar Institute describe how they increase the effectiveness of anti-melanoma drugs by combining anticancer therapies with diabetes drugs.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John David Hayes, MD 3100 Maccorkle Ave Se, Ste 203, Charleston, WV 25304-1228 Ph: (304) 388-1724 | John David Hayes, MD 210 Brooks St, Suite 200, Charleston, WV 25301-1855 Ph: (304) 388-1930 |
News Archive
If hospital doctors around the world often struggle to become those health centaurs, half professionals and half managers, that modern healthcare organizations need, the main responsibility is not their resistance to change, but the lack of effective support from the organization, according to a study by Marco Sartirana (CERGAS, Bocconi University), Graeme Currie (Warwick Business School), and Mirko Noordegraaf (Utrecht School of Governance), published by the Public Management Review.
Veracyte, Inc., a molecular diagnostics company pioneering the field of molecular cytology, today announced that two Blue Cross Blue Shield–affiliated organizations, Highmark Inc. and Horizon Blue Cross Blue Shield of New Jersey, have issued positive coverage policies for the company's Afirma Gene Expression Classifier (GEC).
Calbiotech, Inc. announced today that it has been awarded a Small Business Innovative Research (SBIR) Phase I contract by the U.S. Army Medical Research and Material command. Under terms of the agreement, Calbiotech will develop analyte specific reagents (ASRs) for the diagnosis of Dengue virus.
Advanced metastatic melanoma is a disease that has proven difficult to eradicate. Despite the success of melanoma-targeting drugs, tumors inevitably become drug resistant and return, more aggressive than before. In the current issue of the journal Cancer Cell, however, researchers at The Wistar Institute describe how they increase the effectiveness of anti-melanoma drugs by combining anticancer therapies with diabetes drugs.
› Verified 8 days ago
Ghulam Abbas, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3100 Maccorkle Ave Se Ste 101, Charleston, WV 25304 Phone: 304-388-5395 Fax: 304-388-5398 | |
Dr. Jacob Minor, DO Surgery Medicare: Medicare Enrolled Practice Location: 3100 Maccorkle Ave Se Ste 700, Charleston, WV 25304 Phone: 304-351-1600 Fax: 304-351-1604 | |
Edward Henry Tiley Iii, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 9 Courtney Dr, Charleston, WV 25304 Phone: 304-925-3115 Fax: 304-925-2088 | |
Dr. Luke Weldon Martin, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 331 Laidley St Ste 503, Charleston, WV 25301 Phone: 304-205-7912 Fax: 304-205-4694 | |
Dr. Shadi J Abu-halimah, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 415 Morris St, Suite 105, Charleston, WV 25301 Phone: 304-388-6412 Fax: 304-388-6416 | |
Dr. Michael Elmore, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3100 Maccorkle Ave Se, Ste 700, Charleston, WV 25304 Phone: 304-556-3810 Fax: 304-347-1397 | |
Dr. Eric P Mantz, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 600 Morris St, Suite 103, Charleston, WV 25301 Phone: 304-388-7040 Fax: 304-388-7041 |